PTGX vs WTW · rev $269.8M vs P/E 15, rev $4.88B
Protagonist Therapeutics Inc (PTGX) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
PTGX currently screens at market cap $7.25B. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the PTGX and WTW stock pages for the full models.
Not investment advice.